Anette Varbo

9.2k total citations · 6 hit papers
57 papers, 5.8k citations indexed

About

Anette Varbo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Anette Varbo has authored 57 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 37 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in Anette Varbo's work include Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Lipoproteins and Cardiovascular Health (33 papers) and Cancer, Lipids, and Metabolism (14 papers). Anette Varbo is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Lipoproteins and Cardiovascular Health (33 papers) and Cancer, Lipids, and Metabolism (14 papers). Anette Varbo collaborates with scholars based in Denmark, United Kingdom and United States. Anette Varbo's co-authors include Børge G. Nordestgaard, Christian M. Madsen, Marianne Benn, Anne Tybjærg‐Hansen, Ruth Frikke‐Schmidt, Anne Langsted, Anders Berg Jørgensen, J Freiberg, Pia R. Kamstrup and George Davey Smith and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Anette Varbo

55 papers receiving 5.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Triglycerides and cardiovascular disease

2014 1.0k citations Børge G. Nordestgaard, Anette Varbo The Lancet profile →
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

2012 759 citations Anette Varbo, Marianne Benn et al. Journal of the American College of Cardiology profile →
Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies

2017 467 citations Christian M. Madsen, Anette Varbo et al. European Heart Journal profile →
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

2013 462 citations Anette Varbo, Marianne Benn et al. profile →
Worldwide Prevalence of Familial Hypercholesterolemia

2020 349 citations Christian M. Madsen, Anette Varbo et al. Journal of the American College of Cardiology profile →
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial

2024 73 citations Barbara McGowan, Jens Meldgaard Bruun et al. The Lancet Diabetes & Endocrinology profile →

Peers

Countries citing papers authored by Anette Varbo

Since Specialization

Citations

This map shows the geographic impact of Anette Varbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anette Varbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anette Varbo more than expected).

Fields of papers citing papers by Anette Varbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anette Varbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anette Varbo. The network helps show where Anette Varbo may publish in the future.

Co-authorship network of co-authors of Anette Varbo

This figure shows the co-authorship network connecting the top 25 collaborators of Anette Varbo. A scholar is included among the top collaborators of Anette Varbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anette Varbo. Anette Varbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Remnant Cholesterol: Quantification, Concentrations by Sex and Age, and Risk of Ischemic Heart Disease 2024 ·Clinical Chemistry ·Mie Balling, Shoaib Afzal, Anette Varbo, Børge G. Nordestgaard, Anne Langsted	2
2	Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial breakdown → 2024 ·The Lancet Diabetes & Endocrinology ·Barbara McGowan, Jens Meldgaard Bruun, (unknown), Sue D. Pedersen, Kirsi H. Pietiläinen, (unknown), (unknown), Anette Varbo, David C.W. Lau	73
3	Obesity, Cardiorenal Comorbidities, and Risk of Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction 2023 ·Mayo Clinic Proceedings ·Camilla S. Morgen, Christiane L. Haase, Tuğçe Kalaycı Oral, Volker Schnecke, Anette Varbo, Barry A. Borlaug	20
4	Elevated LDL Triglycerides and Atherosclerotic Risk 2023 ·Journal of the American College of Cardiology ·Mie Balling, Shoaib Afzal, George Davey Smith, Anette Varbo, Anne Langsted, Pia R. Kamstrup, Børge G. Nordestgaard	63
5	Hypertriglyceridemia-Associated Pancreatitis: New Concepts and Potential Mechanisms 2023 ·Clinical Chemistry ·(unknown), Anette Varbo, Børge G. Nordestgaard, Anne Langsted	26
6	Low and high pancreatic amylase is associated with pancreatic cancer and chronic pancreatitis 2021 ·European Journal of Epidemiology ·(unknown), Anne Langsted, Anette Varbo, Christian M. Madsen, Anne Tybjærg‐Hansen, Børge G. Nordestgaard	10
7	Worldwide Prevalence of Familial Hypercholesterolemia breakdown → 2020 ·Journal of the American College of Cardiology ·(unknown), Christian M. Madsen, Anette Varbo, Børge G. Nordestgaard	349
8	VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins 2020 ·Journal of the American College of Cardiology ·Mie Balling, Shoaib Afzal, Anette Varbo, Anne Langsted, George Davey Smith, Børge G. Nordestgaard	123
9	Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study 2017 ·European Heart Journal ·Christian M. Madsen, Anette Varbo, Børge G. Nordestgaard	33
10	Filaggrin loss‐of‐function mutations as risk factors for ischemic stroke in the general population 2017 ·Journal of Thrombosis and Haemostasis ·Anette Varbo, Børge G. Nordestgaard, Marianne Benn	8
11	2.6-fold risk of ischemic stroke in individuals with clinical familial hypercholesterolemia: The copenhagen general population study with 102,961 individuals 2017 ·Atherosclerosis ·(unknown), Christian M. Madsen, Anette Varbo, Børge G. Nordestgaard	2
12	Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100 578 Individuals from the General Population 2015 ·The Journal of Clinical Endocrinology & Metabolism ·Anne Langsted, Anette Varbo, Pia R. Kamstrup, Børge G. Nordestgaard	42
13	Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98 529 Danish adults 2015 ·International Journal of Epidemiology ·Helle K M Bergholdt, Børge G. Nordestgaard, Anette Varbo, Christina Ellervik	37
14	Disminución de triglicéridos sin ayuno y reducción de mortalidad por cualquier causa: un estudio de randomización mendeliana 2014 ·Acta bioquímica clínica latinoamericana ·(unknown), Anette Varbo, Anne Tybjærg‐Hansen, Børge G. Nordestgaard	1
15	Triglycerides and cardiovascular disease breakdown → 2014 ·The Lancet ·Børge G. Nordestgaard, Anette Varbo	1016
16	Remnant cholesterol and ischemic heart disease 2014 ·Current Opinion in Lipidology ·Anette Varbo, Børge G. Nordestgaard	40
17	Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment 2013 ·Pharmacology & Therapeutics ·Anette Varbo, Marianne Benn, Børge G. Nordestgaard	175
18	Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease breakdown → 2012 ·Journal of the American College of Cardiology ·Anette Varbo, Marianne Benn, Anne Tybjærg‐Hansen, Anders Berg Jørgensen, Ruth Frikke‐Schmidt, Børge G. Nordestgaard	759
19	Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population 2011 ·Annals of Neurology ·Anette Varbo, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Peter Schnohr, Gorm Boje Jensen, Marianne Benn	98
20	In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978–2007—a nationwide population-based study 2011 ·Gynecologic Oncology ·Louise Baandrup, Anette Varbo, Christian Munk, Christoffer Johansen, Morten Frisch, Susanne K. Kjær	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact